These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1471145)

  • 1. DRB5*HK: a new HLA-DRB5 allele in Cantonese.
    Grooms A; Dunckley H; Gao X; Serjeantson SW
    Tissue Antigens; 1992 Oct; 40(4):210-1. PubMed ID: 1471145
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a new HLA-DRB5 allele, DRB5*0112, by routine PCR-SSP.
    Atkinson DC; Jobson SE; Dunn PP; Briggs DC
    Tissue Antigens; 2003 Dec; 62(6):554-5. PubMed ID: 14617041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel DRB1*11 (DRB1*11013, DRB1*1129), DRB1*08 (DRB1*0816) and DRB5* (DRB5*0107) alleles.
    Buyse IM; Couture C; Hashemi-Tavoularis S
    Tissue Antigens; 1997 Dec; 50(6):678-81. PubMed ID: 9458128
    [No Abstract]   [Full Text] [Related]  

  • 4. Two DR2-associated novel alleles arose from the silent mutation of codon 72: DRB1*16012, DRB5*01012.
    Lin YS; Tang TF; Ng J; Hartzman R; Hurley CK
    Tissue Antigens; 1999 Oct; 54(4):405-8. PubMed ID: 10551425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HLA-haplotype containing a DRB5 gene not associated with DRB1*15 or DRB1*16 alleles.
    Tautz C; Marsh DG; Baur X
    Tissue Antigens; 1992 Feb; 39(2):91-4. PubMed ID: 1574803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N).
    Voorter CE; Roeffaers HE; du Toit ED; van den Berg-Loonen EM
    Tissue Antigens; 1997 Oct; 50(4):326-33. PubMed ID: 9349614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family.
    Balas A; Ocon P; Vicario JL; Alonso A
    Tissue Antigens; 2000 May; 55(5):467-9. PubMed ID: 10885571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele.
    Fogdell A; Hillert J; Sachs C; Olerup O
    Tissue Antigens; 1995 Oct; 46(4):333-6. PubMed ID: 8560455
    [No Abstract]   [Full Text] [Related]  

  • 9. The monoclonal antibody TAL16.1 recognizes the aspartic acid residue at position 70 in DRB gene products.
    Sadler AM; Heyes JM; Marsh SG; Krausa P; Reynolds GE; Bodmer JG
    Tissue Antigens; 1993 Jan; 41(1):42-6. PubMed ID: 7681224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new allele, HLA-DRB5*0113, through three different molecular biology techniques.
    Garino E; Berrino M; Bertinetto F; Caropreso P; Chidichimo R; Dametto E; Fasano ME; Frisaldi E; Mazzola G; Tondat F; Boccadoro M; Bruno B; Amoroso A
    Tissue Antigens; 2006 May; 67(5):427-9. PubMed ID: 16671952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide typing analysis for the linkage disequilibrium between the polymorphic DRB1 and DRB5 loci in DR2 haplotypes.
    Tiercy JM; Jeannet M; Mach B
    Tissue Antigens; 1991 Apr; 37(4):161-4. PubMed ID: 1926124
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DRB5 genotyping by PCR-RFLP.
    Trejaut J; Dunckley H
    Tissue Antigens; 1994 Jan; 43(1):60-3. PubMed ID: 7912860
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a new HLA-DRB5 allele (DRB5*0105) by PCR-SSP and direct sequencing.
    Poli F; Bianchi P; Crespiatico L; Terragna C; van den Berg-Loonen E; Sirchia G
    Tissue Antigens; 1996 Apr; 47(4):338-40. PubMed ID: 8773325
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of the new HLA-DRB5*01:01:01:02 allele in a Chinese individual.
    Wu R; Peng D; Wang N; Sun H; Li J
    HLA; 2019 Jan; 93(1):56-57. PubMed ID: 30430763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new allele, HLA-DRB1*1360, on a DRB5 haplotype in a Brazilian individual.
    Testa GV; Bunce M; Sheldon MH; Dunn PP; Day S; Marques SB
    Tissue Antigens; 2004 Jun; 63(6):617-8. PubMed ID: 15140048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the novel HLA-DRB5*01:01:01:07 allele by Pacific Biosciences HiFi sequencing in a Chinese individual.
    Li Z; Han Y; Yang X; Zhang W; Gao P
    HLA; 2024 Jun; 103(6):e15550. PubMed ID: 38887899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients.
    Kaneoka H; Hsu KC; Takeda Y; Sharp GC; Hoffman RW
    Arthritis Rheum; 1992 Jan; 35(1):83-94. PubMed ID: 1370621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel HLA-DR4 allele (DRB1*0414) in a patient with myasthenia gravis.
    Pile KD; Willcox N; Bell JI; Wordsworth BP
    Tissue Antigens; 1992 Nov; 40(5):264-6. PubMed ID: 1481204
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
    Loh MT; Chan SH; Ren EC
    Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*).
    Li D; Gao HF; Liu X; Jiang D; Li Z; Liu YH; Jiang YZ; Li L; Lan GX; Zhao CZ; Guo T; Cai B; Wang D; Sun GY; Zhang D; Lu DP
    Tissue Antigens; 2005 Jul; 66(1):67-8. PubMed ID: 15982264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.